AUM
$301M
Estimated Dry Powder
Not publicly reported
Fund Size (Latest)
Not publicly reported
Estimated Cheque Size
$1.4M-$13.5M
Stages
- Seed
- Series A
- Series B
Fund Details
Year Established
2010
HQ
Binger Strasse 173, Ingelheim am Rhein, 55216, Germany, Europe
HQ Phone
+49 6132 77145108
About
Boehringer Ingelheim Venture is the corporate venture arm of Boehringer Ingelheim, a global pharmaceutical company. The firm makes early-stage investments worldwide and channels its investments into innovative pharmaceutical and medical technologies companies, with a focus on next-generation vaccines, NBEs, and regenerative medicine.
HQ Map
No mappable locations available.
Locations